Growth Metrics

908 Devices (MASS) Net Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -388.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -315.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,018.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 399.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 908 Devices 314.43 Mn 202.69 Mn 6.88 Mn 4,275.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4,275.00
Dec 31, 2025 8,292.00
Sep 30, 2025 -6,735.00
Jun 30, 2025 -2,915.00
Mar 31, 2025 48,305.00
Dec 31, 2024 -198.00
Sep 30, 2024 -16,044.00
Jun 30, 2024 -1,893.00
Mar 31, 2024 -3,713.00
Dec 31, 2023 12,738.00
Sep 30, 2023 -2,079.00
Jun 30, 2023 -9,398.00
Mar 31, 2023 -5,722.00